🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
PF-05180999 is a phosphodiesterase-2 inhibitor that is hypothesized to be a...
Status
Terminated
Location
Pfizer Investigational Site
Start Date
2014-01
Trial ID
NCT01981499
Treatments Being Tested
Open-label, two-parallel-arm, controlled randomized clinical trial testing ...
Status
Completed
Location
IRCCS Istituto Giannina Gaslini
Start Date
2015-06
Trial ID
NCT02394119
Treatments Being Tested
This study will assess the ability of montelukast to improve the signs and ...
Status
Completed
Location
Multiple Locations
Start Date
2001-11
Trial ID
NCT00974571
Treatments Being Tested
The purpose of this study is to evaluate the onset and duration of action o...
Status
Completed
Location
Ora, Inc.
Start Date
2013-06
Trial ID
NCT01881113
Treatments Being Tested
The purpose of this study is to determine whether cetirizine (zyrtec), levo...
Status
Completed
Location
Vanderbilt University Asthma, Sinus, and Allergy Clinic
Start Date
2009-01
Trial ID
NCT00826943
Treatments Being Tested
Ketotifen is an established antihistamine drug, widely used in pediatric cl...
Status
Completed
Location
Multiple Locations
Start Date
2002-08
Trial ID
NCT00639587
Treatments Being Tested
Background Allergic Rhinitis is a chronic Th2-mediated inflammatory disorde...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2028-06-30
Trial ID
NCT07626099
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of different concentr...
Status
Completed
Location
Ora, Inc.
Start Date
2011-04
Trial ID
NCT01332188
Treatments Being Tested
This study will determine the capacity of more frequent dosing of QAV680 to...
Status
Completed
Location
Novartis Investigative Site
Start Date
2010-03-22
Trial ID
NCT01103050
Patients with chronic HBV infection will receive either ARC-520 or placebo ...
Status
Terminated
Location
Research Site 1
Start Date
2015-09
Trial ID
NCT02604199
Treatments Being Tested